If you have not already registered for Full Text Access to The Journal, then visit our registration page.
Many supplements are available to the general public for a limited time on our SuppleNet page.


VOLUME 59   1998   SUPPLEMENT 12

Articles

3 Measuring Outcome in Schizophrenia: Differences Among the Atypical Antipsychotics. Collaborative Working Group on Clinical Trial Evaluations
[Abstract] [PDF]

10 Clinical Development of Atypical Antipsychotics: Research Design and Evaluation. Collaborative Working Group on Clinical Trial Evaluations
[Abstract] [PDF]

17 Adverse Effects of the Atypical Antipsychotics. Collaborative Working Group on Clinical Trial Evaluations
[Abstract] [PDF]

23 Assessment of EPS and Tardive Dyskinesia in Clinical Trials. Collaborative Working Group on Clinical Trial Evaluations
[Abstract] [PDF]

28 Assessing the Effects of Atypical Antipsychotics on Negative Symptoms. Collaborative Working Group on Clinical Trial Evaluations
[Abstract] [PDF]

35 Evaluating the Effects of Antipsychotics on Cognition in Schizophrenia. Collaborative Working Group on Clinical Trial Evaluations
[Abstract] [PDF]

41 Atypical Antipsychotics for Treatment of Depression in Schizophrenia and Affective Disorders. Collaborative Working Group on Clinical Trial Evaluations
[Abstract] [PDF]

46 Treatment of Special Populations With the Atypical Antipsychotics. Collaborative Working Group on Clinical Trial Evaluations
[Abstract] [PDF]

CME Section

53 Instructions and Posttest.
[PDF]

55 Registration and Evaluation.
[PDF]